News About: Pharm. Affairs
Handok-Genexine co-develop growth hormone, selected as orphan drug from FDA
‘GX-H9,’ a long-acting growth hormone that is being co-developed by Handok(Chairman Young-Jin Kim) and Genexine(CEO Han-Soo Kyung), was selected as an orphan drug to treat growth hormone deficiency from the U.S. Food ...
Hepatitis B therapy ‘Virea’ sold for more than KRW 100 billion in 9 months
The collective sales of the Yuhan Corporation’s hepatitis B treatment ‘Viread’ by the last September were aggregated to exceed KRW 100 billion.
According to Yuhan Corporation, its 2016 third quarter’s collective sale...
Additional bill tabled for foreign pharmacists to take preliminary test before national examination
An additional bill to have foreign pharmacist license owners pass a preliminary test before taking a national examination for the Korean pharmacist license was tabled.
The Minjoo Party Rep. Seung-Jo Yang tabled the ...
Phase 3 clinical trial result of Hanmi Pharm’s ‘Rovelito’ registered at intern. journalThe Phase 3 clinical trial result of Hanmi Pharm’s hypertension and hyperlipidemia complex ‘Rovelito’ was registered at a SCI-level international academic journal.
On the 9th, ...
|
Issue on illegality of IMS Health… will it impact big data industry?
“The ruling could be an incident that becomes a touchstone of the big data industry. Other countries are paying attention to it, too.”
This is another viewpoint to see results of the criminal trials for the Korea Pha...
5 drugs, such as Bearse, Wonbi-D & Zantac, show twice drug gaps
According to the result of ‘2016 Price Survey on Commonly Consumed Drugs’ released by the Ministry of Health and Welfare, 5 products, such as Guronsanvarmond Yungjin Soln, Haben Herb Cap, Kimite Patch For Adult, Bears...
High chance remote drug dispensers to be tabled within this year
There is a high chance an amendment to the Pharmaceutical Affairs Law for implementation of remote drug dispensers will be tabled within this year.
According to the Ministry of Health and Welfare(MOHW), the amendmen...
CorePharm Bio wins patent infringement trial against Astellas
CorePharm Bio won the prohibition trial for patent infringement against Astellas Pharma.
CorePharm Bio(CEO Jung-Tae Kim) announced the 13 Civil Case Division of Seoul Central District Court ruled CorePharm Bio’s A-C...
Daewoong sells calcium product of KRW 72.8 billion to AbbottOn the 2nd, Daewoong Pharmaceutical officially announced a KRW 72.8 billion exclusive sales agreement of ‘Pitavastatin Calcium Tab’ in 4 East Asian countries, including Thailand...
|
Green Cross first acquires approval of tetanus & diphtheria vaccine in KoreaGreen Cross has once again succeeded in localizing a basic vaccine.
On the 2nd, Green Cross(CEO Eun-Cheol Huh) announced it acquired product approval of the adult tetanus & dip...
|
